SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Activity

22 hedge funds and large institutions have $671K invested in Salarius Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 5 closing their positions.

Holders
22
Holders Change
-5
Holders Change %
-18.52%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
9
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$124K
2
HKAM
2
Horizon Kinetics Asset Management
New York
$12K

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$264K
2
Millennium Management
2
Millennium Management
New York
$23K
3
Citadel Advisors
3
Citadel Advisors
Florida
$0
4
VF
4
Virtu Financial
New York
$0
5
TRCT
5
Tower Research Capital (TRC)
New York
$5K
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
26
Concourse Financial Group Securities
Alabama
– – – –
BlackRock
27
BlackRock
New York
$0 1,197 – –
Morgan Stanley
28
Morgan Stanley
New York
$0 1,502 +2 +0.1%
1
2